Ameriprise Financial Inc Reata Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $6.69 Million - $8.89 Million	84,396 Added 1570.16%	89,771 $9.15 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $112,324 - $339,231	-3,641 Reduced 40.38%	5,375 $488,000
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $18,295 - $34,782	826 Added 10.09%	9,016 $342,000
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $158,967 - $298,853	8,190 New	8,190 $205,000
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $77,214 - $334,544	-3,015 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $10 Million - $14.3 Million	-100,211 Reduced 97.08%	3,015 $304,000
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $38,508 - $74,434	492 Added 0.48%	103,226 $14.6 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $2.19 Million - $3.09 Million	23,281 Added 29.3%	102,734 $10.2 Million
Q4 2020 Feb 12, 2021	BUY	$102.03 - $184.62 $1.94 Million - $3.5 Million	18,978 Added 31.38%	79,453 $9.82 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $16.9 Million - $29.5 Million	-180,393 Reduced 74.89%	60,475 $5.89 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $3.27 Million - $4.57 Million	25,897 Added 12.05%	240,868 $37.6 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $13.2 Million - $26.3 Million	106,305 Added 97.83%	214,971 $31 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.73 Million - $5.07 Million	23,255 Added 27.23%	108,666 $22.2 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $3.24 Million - $4.35 Million	-45,475 Reduced 34.74%	85,411 $6.86 Million
Q2 2019 Aug 14, 2019	BUY	$77.72 - $94.35 $832,614 - $1.01 Million	10,713 Added 8.91%	130,886 $12.3 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $3.16 Million - $6.2 Million	-60,904 Reduced 33.63%	120,173 $10.3 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $2.56 Million - $4.02 Million	-52,551 Reduced 22.49%	181,077 $10.2 Million
Q3 2018 Nov 14, 2018	SELL	$35.64 - $92.06 $6.17 Million - $15.9 Million	-173,095 Reduced 42.56%	233,628 $19.1 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $7.49 Million - $15.4 Million	375,446 Added 1200.39%	406,723 $14.2 Million
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $6,440 - $9,721	-322 Reduced 1.02%	31,277 $641,000
Q4 2017 Feb 12, 2018	SELL	$22.39 - $33.27 $9,941 - $14,771	-444 Reduced 1.39%	31,599 $895,000
Q3 2017 Nov 07, 2017	BUY	$26.29 - $31.88 $842,410 - $1.02 Million	32,043	32,043 $997,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account